ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Deriv

Opere Ahora

Deriv
Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
4,967.23
-0.88%
Dow Jones
37,986.40
0.56%
US Dollar vs MXN
17.1005
0.00%
Brent Oil
86.625
0.00%
Bitcoin
63,730.86
-0.15%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. BioNTech SE (BNTX)

  7. BioNTech SE (BNTX) Noticias

BNTX BioNTech SE

86.81
0.64 (0.74%)
19 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
BioNTech SE BNTX NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.64 0.74% 86.81 16:49:14
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
85.70 85.625 87.59 86.81 86.17
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/4/202413:00GLOBEThree-year Phase 1 Follow-Up Data for mRNA-based..
21/3/202406:17IHMARKETNEWSApple Pre-Market Drop Due to Antitrust Threats, Surprising..
20/3/202406:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
20/3/202405:15GLOBEBioNTech Announces Fourth Quarter and Full Year 2023..
20/3/202405:00GLOBEBioNTech Announces Appointment of Annemarie Hanekamp to..
11/3/202408:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/3/202406:45GLOBEBioNTech to Present Clinical Data Updates for Personalized..
11/3/202405:25PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
07/3/202407:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/3/202405:45GLOBEBioNTech Announces Planned Retirement of Sean Marett
06/3/202405:45GLOBEBioNTech to Report Fourth Quarter and Full Year 2023..
05/3/202404:45PRNUSThe Gross Law Firm Reminds BioNTech SE Investors of the..
28/2/202417:26EDGAR2Form 144 - Report of proposed sale of securities
26/2/202404:45PRNUSShareholders that lost money on BioNTech SE(BNTX) Urged to..
22/2/202404:45PRNUSBioNTech SE Sued for Securities Law Violations - Contact The..
15/2/202415:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/2/202404:00PRNUSShareholders that lost money on BioNTech SE(BNTX) Urged to..
14/2/202406:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202404:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
08/2/202405:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/2/202404:45GLOBEBioNTech and Autolus Announce Strategic CAR-T Cell Therapy..
07/2/202416:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202404:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
31/1/202406:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202405:45GLOBEBioNTech and DualityBio Receive FDA Fast Track Designation..
26/1/202404:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
22/1/202408:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/1/202405:45GLOBEBioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of..
19/1/202404:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
10/1/202405:21IHMARKETNEWSWall Street Highlights: Tesla Launches Restyled Model 3,..
09/1/202413:57DJNBioNTech Shares Down 3.4%; Sees 2024 Revenue Below Wall..
09/1/202406:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202405:45GLOBEBioNTech Outlines 2024 Strategic Priorities at the 42nd..
04/1/202407:02EDGAR2Form 144 - Report of proposed sale of securities
21/12/202315:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202307:00GLOBEBioNTech and DualityBio Receive FDA Breakthrough Therapy..
19/12/202311:12DJNCureVac Shares Hit All-Time Low on German Patent Court..
18/12/202315:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/12/202312:15GLOBEBioNTech Achieves Milestone at mRNA-based Vaccine..
13/12/202307:31DJNModerna Shares, Other Covid Vaccine Makers Hit by Warning..
12/12/202305:45GLOBEBioNTech to Inaugurate First African Site on December 18,..
07/11/202307:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202313:22DJNTrending: BioNTech Reports Surprise Profit, Cuts Outlook
06/11/202306:17DJNBioNTech Warns on Covid-19 Vaccine Revenue, Lowers Spending..
06/11/202305:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202305:54IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
06/11/202305:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202305:45GLOBEBioNTech Announces Third Quarter 2023 Financial Results and..
26/10/202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202305:45BWPfizer and BioNTech Announce Positive Topline Data for..

Su Consulta Reciente

NASDAQ
BNTX
BioNTech
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados